官方服务：
资源简介：
Treatment time on EGFR TKIs.
应用场景：
创建时间：
2018-11-27
相关数据集
Metadata record for the manuscript: Molecular landscape and efficacy of HER2-targeted therapy in patients with HER2-mutated metastatic breast cancer
Summary This metadata record provides details of the data supporting the claims of the related manuscript: “Molecular landscape and efficacy of HER2-targeted therapy in patients with HER2-mutated me
NIAID Data Ecosystem70
Genome-wide CRISPR screening reveals genetic modifiers of mutant EGFR dependence in NSCLC
Human non-small-cell lung cancers (NSCLCs) harboring activating mutations in epidermal growth factor receptor (EGFR) frequently respond to EGFR tyrosine kinase inhibitors (TKIs), such as erlotinib and
NIAID Data Ecosystem60
MicroRNA and mRNA regulatory network in EGFR-mutated lung adenocarcinoma [miRNA]. MicroRNA and mRNA regulatory network in EGFR-mutated lung adenocarcinoma [miRNA]
We have examined the both miRNA and mRNA expression profiles in 155 lung adenocarcinoma samples with known EGFR mutation status (52 mutated and 103 wild-type cases). An integrative analysis was perfor
NIAID Data Ecosystem40
Additional file 3: of iCAGES: integrated CAncer GEnome Score for comprehensively prioritizing driver genes in personal cancer genomes
Table of targeted therapy TCGA samples with progressive disease. (XLSX 9Â kb)
Figshare2016-12-23 更新70
Treatment response comparison between patients with or without deterioration of Child-Pugh scores during treatment with lenvatinib for HCC.
Treatment response comparison between patients with or without deterioration of Child-Pugh scores during treatment with lenvatinib for HCC.
Figshare2021-03-01 更新40
